Skip to Main Content

Paper Details

The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment.
Mol Cancer Res
27
2019
Cisplatin, KIT G565R, KIT G565R activating mutation, Metastatic Osteosarcoma, NF1, NF1 missense mutations, TP53, cisplatin, metastatic osteosarcoma, metastatic pediatric osteosarcoma, minor clone, osteosarcoma, patient, patients, pediatric cancers, primary, relapse-specific lineages, tumors
Author NameAffiliation
Xiaotu MaSt. Jude Children's Research Hospital
Xiaotu MaSt. Jude Children's Research Hospital
Michael RuschSt. Jude Children's Research Hospital
Michael RuschSt. Jude Children's Research Hospital
Michael N EdmonsonSt. Jude Children's Research Hospital
Michael N EdmonsonSt. Jude Children's Research Hospital
John EastonSt. Jude Children's Research Hospital
John EastonSt. Jude Children's Research Hospital
Ludmil B AlexandrovUniversity of California
Ludmil B AlexandrovUniversity of California
Xiang ChenSt. Jude Children's Research Hospital
Xiang ChenSt. Jude Children's Research Hospital
Elaine R MardisInstitute for Genomic Medicine, Nationwide Children's Hospital and The Ohio State University College of Medicine
Elaine R MardisInstitute for Genomic Medicine, Nationwide Children's Hospital and The Ohio State University College of Medicine
Richard K WilsonInstitute for Genomic Medicine, Nationwide Children's Hospital and The Ohio State University College of Medicine
Richard K WilsonInstitute for Genomic Medicine, Nationwide Children's Hospital and The Ohio State University College of Medicine
Alberto S PappoSt. Jude Children's Research Hospital
Benjamin J RaphaelPrinceton University
Jinghui ZhangSt. Jude Children's Research Hospital
Jinghui ZhangSt. Jude Children's Research Hospital
  • 1 - 20

Datasets